Selecting a Brief Cognitive Screening Test Based on Patient Profile: It Is Never Too Early to Start.

ABSTRACT: Introduction: Cognitive impairment, marked by a decline in memory and attention, is frequently underdiagnosed, complicating effective management. Cardiovascular risk factors (CVR) and anticholinergic burden (ACB) are significant contributors to dementia risk, with ACB often stemming from medications prescribed for neuropsychiatric disorders. This study evaluates cognitive profiles through three brief cognitive tests, analyzing the impact of CVR and ACB presence. Methods: This cross-sectional study was performed between 2019 and 2023 in community pharmacies and an outpatient clinic in Valencia, Spain. Eligible participants were patients with subjective memory complaints 50 years or older with clinical records of cardiovascular factors. Patients with conflicting information reg

SUBMITTER: Garcia-Lluch G 

PROVIDER: S-EPMC11477581 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature